Desk›Healthcare› Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Ltd
BSE 500124 · NSE DRREDDY · ISIN INE089A01031 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,175.00
-0.96%
BSE close, 28 August 2026
₹98,069.82 cr
83.5 cr shares · Mid cap
₹71,459.26 cr
as published
147.8× · 3.64×
EPS ₹7.95 · BV ₹322.80
20,532.80 / 3,219.70
₹ cr, as filed
36
9 selected · 25%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -16.9% |
|---|---|
| Against 52-week low | +8.8% |
| Day change | -0.96% |
| Size band | Mid cap |
| Index membership | NIFTY 50, NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹7.95 |
|---|---|
| Price / earnings | 147.80× |
| Price / book | 3.64× |
| Book value — derived, price ÷ P/B | ₹322.80 |
| Return on equity | 2.46% |
| Operating margin | 17.28% |
| Net margin | 7.88% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 2.46%
- ROE as published
- 2.46%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 5,136.60 | 404.70 | 4.86 | 17.28% | 7.88% |
| Mar-26 · Q | 3,822.00 | -219.40 | -2.63 | 1.76% | -5.74% |
| FY25-26 | 20,532.80 | 3,219.70 | 38.68 | 27.31% | 15.68% |
Quarter on quarter
- Revenue, quarter on quarter
- +34.4%
- Net profit, quarter on quarter
- +284.5%
- Operating margin, quarter on quarter
- +1,552 bps
Disclosure profile 36 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 3 |
| Press Release | 3 |
| Board Outcome | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 9 |
| Procedural | |
| General | 11 |
| Analyst / Investor Meet | 3 |
| Newspaper Publication | 3 |
| AGM / EGM | 2 |
| Clarification | 2 |
| ESOP Allotment | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 27 |
| Total | 36 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
36 filings · 9 selected · busiest 2026-07-22 and 2026-07-23
Filing rhythm · the twelve most recent
2026-09-102026-10-08
SelectedProcedural
Filings
36 in the window · 20 earlier on record
-
8 October 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
7 October 2026 ·
Press Release / Media Release
Intimation of Earnings call
Company Update / Press Release / Media Release View filing →
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
22 September 2026 ·
Closure of Trading Window
Closure of Trading window
Insider Trading / SAST / Closure of Trading Window View filing →
-
22 September 2026 ·
Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ending September 30, 2026.
Dr Reddys Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Standalone ....
Board Meeting / Board Meeting View filing →
-
21 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of analyst meet
Company Update / Analyst / Investor Meet View filing →
-
18 September 2026 ·
Press Release / Media Release
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / Press Release / Media Release View filing →
-
18 September 2026 ·
Clarification-Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Clarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
17 September 2026 ·
Clarification sought from Dr Reddys Laboratories Ltd
The Exchange has sought clarification from Dr Reddys Laboratories Ltd on September 17, 2026, with reference to news appeared in https://pharma.economictimes.indiatimes.com/ dated September ....
Company Update / Clarification
-
16 September 2026 ·
Newspaper Publication
Copies of newspaper publication
Company Update / Newspaper Publication View filing →
-
11 September 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
10 September 2026 ·
Allotment of ESOP / ESPS
Allotment of Employee Stock options
Company Update / Allotment of ESOP / ESPS View filing →
-
10 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Analyst meet
Company Update / Analyst / Investor Meet View filing →
-
26 August 2026 ·
Allotment of ESOP / ESPS
Allotment of Employee Stock options
Company Update / Allotment of ESOP / ESPS View filing →
-
20 August 2026 ·
Newspaper Publication
Copies of newspaper publication
Company Update / Newspaper Publication View filing →
-
14 August 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
14 August 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
14 August 2026 ·
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
13 August 2026 ·
Change in Management
Change in Senior Management Personnel
Company Update / Change in Management View filing →
-
7 August 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2105
Company Update / General View filing →
-
7 August 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2105
Company Update / General View filing →
-
7 August 2026 ·
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
29 July 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulation, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
29 July 2026 ·
Clarification-Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Clarification- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / General View filing →
-
28 July 2026 ·
Analyst / Investor Meet - Outcome
Transcript of Earnings call recording
Company Update / Analyst / Investor Meet View filing →
-
28 July 2026 ·
Clarification sought from Dr Reddys Laboratories Ltd
The Exchange has sought clarification from Dr Reddys Laboratories Ltd with reference to the media report appearing on https://www.business-standard.com dated July 28, 2026, (Link:https://www.business-standard.com/companies/news/dr-reddys-first-in-class-gonorrhoea-drug-gets-thailand-approval-after-us-nod-126072700632_1.html) ....
Company Update / Clarification
-
23 July 2026 ·
Change in Management
Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015
Company Update / Change in Management View filing →
-
23 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report
AGM/EGM / AGM View filing →
-
23 July 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 42nd Annual General Meeting
AGM/EGM / AGM View filing →
-
23 July 2026 ·
Newspaper Publication
Copy of newspaper publication
Company Update / Newspaper Publication View filing →
-
23 July 2026 ·
Press Release / Media Release
Intimation of Earnings call recordings
Company Update / Press Release / Media Release View filing →
-
22 July 2026 ·
Investor Presentation
Copy of Investor Presentation
Company Update / Investor Presentation View filing →
-
22 July 2026 ·
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Grant of Employee Stock Options
Company Update / General View filing →
-
22 July 2026 ·
Change in Management
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / Change in Management View filing →
-
22 July 2026 ·
Unaudited Financial Results For The Quarter Ended June 30, 2026
Unaudited Financial results for the quarter ended June 30, 2026
Result / Financial Results View filing →
-
22 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting held on July 22, 2026
Board Meeting / Outcome of Board Meeting View filing →
RSS feed for Dr Reddys Laboratories Ltd · the 50 most recent filings